Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Steroids and Adriamycin nephrosis.

T Bertani, G Remuzzi, G Rocchi

    Applied Pathology
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy].

    Ugeskrift for laeger·2001
    Same author

    Challenges to achieving clinical transplantation tolerance.

    The Journal of clinical investigation·2001
    Same author

    Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

    The New England journal of medicine·2001
    Same author

    Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress.

    Blood·2001
    Same author

    Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura.

    Kidney international·2001
    Same author

    Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.

    Kidney international·2001
    Same journal

    Xanthomatous endometritis.

    Applied pathology·1989
    Same journal

    Pulmonary lymphangiomyomatosis. Report of a case with immunohistochemical and ultrastructural findings.

    Applied pathology·1989
    Same journal

    Endomandibular acinic cell carcinoma.

    Applied pathology·1989
    Same journal

    Cystadenofibroma of fallopian tube.

    Applied pathology·1989
    Same journal

    Plasma platelet factor 4 response in rhesus monkeys fed coconut oil.

    Applied pathology·1989
    Same journal

    Assessment of labial salivary gland changes in patients with rheumatoid arthritis by subjective and quantitative methods.

    Applied pathology·1989
    See all related articles

    Adriamycin causes nephrotic syndrome in rats, but steroids like prednisolone did not improve proteinuria or cellular damage. This suggests Adriamycin-induced nephrosis has a different mechanism than other kidney diseases.

    Area of Science:

    • Nephrology
    • Pharmacology
    • Cell Biology

    Background:

    • Adriamycin (doxorubicin) induces nephrotic syndrome in rats.
    • This syndrome features ultrastructural changes in visceral epithelial cells.
    • These changes resemble puromycin aminonucleoside (PA) nephrosis and human minimal change glomerulopathy.

    Purpose of the Study:

    • To investigate the therapeutic effect of steroids on Adriamycin-induced nephrotic syndrome in rats.
    • To compare the mechanisms of Adriamycin nephrosis with PA nephrosis and minimal change glomerulopathy.

    Main Methods:

    • Rats were injected with varying doses of Adriamycin.
    • Subsequent treatment with prednisolone was administered to experimental groups.
    • Proteinuria levels and kidney ultrastructural findings were assessed.

    Related Experiment Videos

    Main Results:

    • No significant differences in proteinuria were observed between control and steroid-treated groups.
    • Ultrastructural examination revealed no significant improvements in visceral epithelial cells with steroid treatment.
    • Steroid therapy did not ameliorate the Adriamycin-induced nephrotic syndrome in rats.

    Conclusions:

    • Steroids like prednisolone are ineffective in treating Adriamycin-induced nephrotic syndrome in rats.
    • The underlying mechanism of Adriamycin nephrosis differs from that of PA nephrosis and human minimal change glomerulopathy.
    • Further research is needed to elucidate the specific pathways involved in Adriamycin-induced kidney injury.